Insider Trading activities of Cardinal Health Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cardinal Health Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cardinal Health Inc since year 2005. Table 2 shows the detailed insider transactions of Cardinal Health Inc since 2005. The reporting company's ticker symbol is CAH. The reporting company's CIK number is 721371.
The total value of stock buying since 2005 is $1,293,399.
The total value of stock sales since 2005 is $397,384,997.
The total value of stock option exercises since 2005 is $223,208,387.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Cardinal Health Inc (CAH).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-05 0 $0 23,270 $1,695,684 23,270 $968,032
2017-02 0 $0 217,994 $16,835,676 217,994 $6,744,734
2016-11 0 $0 217,995 $15,519,064 217,995 $6,744,765
2016-08 0 $0 422,790 $35,248,092 392,820 $13,017,714
2016-05 0 $0 84,617 $6,543,432 84,617 $2,309,197
2015-11 0 $0 84,743 $7,432,397 84,743 $3,123,516
2015-08 1,400 $120,974 300,000 $24,924,000 300,000 $8,187,000
2015-05 0 $0 375,470 $32,435,080 375,470 $11,291,263
2015-03 0 $0 29,403 $2,584,522 29,403 $846,804
2015-02 0 $0 384,617 $32,721,139 384,617 $10,496,197
2014-11 0 $0 24,668 $1,961,106 22,488 $996,218
2014-09 0 $0 91,010 $6,823,239 91,010 $3,740,510
2014-08 0 $0 278,301 $19,705,628 233,587 $9,630,800
2014-07 0 $0 68,012 $4,908,183 44,380 $1,598,825
2014-05 0 $0 42,972 $2,773,176 8,416 $371,650
2014-02 0 $0 764,653 $51,238,438 710,896 $24,468,113
2013-11 0 $0 200,000 $12,542,000 200,000 $8,526,000
2013-09 0 $0 39,463 $2,045,469 42,104 $1,290,513
2013-08 0 $0 196,935 $10,209,426 95,688 $4,036,673
2013-07 0 $0 232,275 $11,604,995 280,075 $9,202,354
2013-06 0 $0 11,070 $537,891 8,255 $365,721
2013-05 435 $20,118 380,439 $17,671,322 398,496 $12,725,466
2013-01 0 $0 186,054 $8,286,717 216,172 $5,896,507
2012-12 0 $0 2,330 $98,442 0 $0
2012-11 0 $0 2,564 $105,688 0 $0
2012-10 0 $0 46,226 $1,849,040 50,000 $1,364,500
2012-09 0 $0 79,410 $3,043,170 50,000 $1,364,500
2012-05 0 $0 8,135 $342,158 9,801 $282,268
2012-02 0 $0 71,546 $2,988,461 71,573 $1,963,683
2011-10 0 $0 44,505 $1,997,079 55,158 $1,505,261
2011-09 0 $0 1,191 $48,997 0 $0
2011-08 0 $0 1,100 $45,903 0 $0
2011-07 0 $0 31,926 $1,481,389 33,036 $916,376
2011-06 0 $0 1,100 $48,169 0 $0
2011-05 0 $0 75,976 $3,432,834 60,884 $2,283,652
2011-04 0 $0 80,005 $3,449,422 72,231 $2,740,344
2011-03 0 $0 177 $7,248 177 $4,053
2011-02 0 $0 87,544 $3,651,460 80,648 $1,882,243
2010-12 0 $0 633 $23,604 0 $0
2009-08 0 $0 20,575 $713,601 21,036 $660,816
2008-10 0 $0 0 $0 562,500 $17,531,437
2008-02 0 $0 0 $0 447,500 $15,563,587
2007-11 20,000 $1,149,860 121,100 $7,272,478 96,402 $3,500,067
2007-10 0 $0 0 $0 3,005 $100,006
2007-06 0 $0 26,597 $1,935,183 569,600 $18,277,278
2007-04 0 $0 5,998 $449,100 5,623 $223,362
2007-03 0 $0 485 $34,051 0 $0
2007-02 0 $0 9,348 $670,384 9,348 $300,565
2007-01 0 $0 25,000 $1,812,500 0 $0
2006-12 0 $0 150,000 $9,866,990 145,409 $3,937,852
2006-09 0 $0 0 $0 2,138 $50,044
2006-08 0 $0 30,350 $2,049,899 14,626 $380,086
2006-05 0 $0 44,672 $3,049,984 44,861 $1,318,810
2006-02 0 $0 19,554 $1,409,882 19,554 $239,536
2006-01 0 $0 0 $0 13,500 $239,489
2005-09 0 $0 10,000 $596,000 0 $0
2005-08 0 $0 65,000 $3,844,945 0 $0
2005-07 0 $0 65,000 $3,767,920 0 $0
2005-06 0 $0 65,000 $3,724,890 0 $0
2005-04 0 $0 65,000 $3,608,540 0 $0
2005-03 0 $0 65,000 $3,718,910 0 $0
2003-01 7 $433 0 $0 0 $0
2002-10 6 $378 0 $0 0 $0
2002-07 8 $423 0 $0 0 $0
2002-04 6 $412 0 $0 0 $0
2002-01 7 $431 0 $0 0 $0
2001-10 5 $370 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Cardinal Health Inc insiders (CAH)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-05-12 Giacomin Jon L (CEO, Pharmaceutical Segment) Sale 23,270 72.87 1,695,684
2017-05-12 Giacomin Jon L (CEO, Pharmaceutical Segment) Option Ex 23,270 41.60 968,032
2017-02-10 Barrett George S (Chairman and CEO) Sale 217,994 77.23 16,835,676
2017-02-10 Barrett George S (Chairman and CEO) Option Ex 217,994 30.94 6,744,734
2016-11-10 Barrett George S (Chairman and CEO) Sale 217,995 71.19 15,519,064
2016-11-10 Barrett George S (Chairman and CEO) Option Ex 217,995 30.94 6,744,765
2016-08-18 Laws Stuart G (SVP & Chief Accounting Officer) Sale 9,703 82.45 800,012
2016-08-18 Morrison Patricia (Chief Information Officer) Sale 43,959 82.50 3,626,617
2016-08-18 Morrison Patricia (Chief Information Officer) Option Ex 43,959 39.81 1,750,007
2016-08-16 Giacomin Jon L (CEO, Pharmaceutical Segment) Sale 47,251 82.77 3,910,965
2016-08-16 Giacomin Jon L (CEO, Pharmaceutical Segment) Option Ex 39,681 28.51 1,131,186
2016-08-11 Morford Craig S (Chief Legal/Compliance Officer) Sale 12,697 83.13 1,055,501
2016-08-10 Barrett George S (Chairman and CEO) Sale 99,754 83.44 8,323,473
2016-08-10 Barrett George S (Chairman and CEO) Option Ex 99,754 30.94 3,086,388
2016-08-10 Casey Donald M Jr. (CEO, Medical Segment) Sale 32,696 83.42 2,727,500
2016-08-10 Casey Donald M Jr. (CEO, Medical Segment) Option Ex 32,696 40.58 1,326,803
2016-08-09 Barrett George S (Chairman and CEO) Sale 129,818 83.76 10,873,555
2016-08-09 Barrett George S (Chairman and CEO) Option Ex 129,818 30.94 4,016,568
2016-08-09 Casey Donald M Jr. (CEO, Medical Segment) Sale 26,484 83.81 2,219,624
2016-08-09 Casey Donald M Jr. (CEO, Medical Segment) Option Ex 26,484 40.58 1,074,720
2016-08-08 Barrett George S (Chairman and CEO) Sale 20,428 83.75 1,710,845
2016-08-08 Barrett George S (Chairman and CEO) Option Ex 20,428 30.94 632,042
2016-05-20 Watkins Carole S (Chief HR Officer) Sale 84,617 77.33 6,543,432
2016-05-20 Watkins Carole S (Chief HR Officer) Option Ex 84,617 27.29 2,309,197
2015-11-10 Barrett George S (Chairman and CEO) Sale 54,658 87.73 4,795,146
2015-11-10 Barrett George S (Chairman and CEO) Option Ex 54,658 27.29 1,491,616
2015-11-06 Stephen Falk T (EVP, Gen. Counsel & Corp. Sec.) Sale 30,085 87.66 2,637,251
2015-11-06 Stephen Falk T (EVP, Gen. Counsel & Corp. Sec.) Option Ex 30,085 54.24 1,631,900
2015-08-20 Barrett George S (Chairman and CEO) Sale 300,000 83.08 24,924,000
2015-08-20 Barrett George S (Chairman and CEO) Option Ex 300,000 27.29 8,187,000
2015-08-06 Anderson David J Buy 1,400 86.41 120,974
2015-05-12 Stephen Falk T (EVP, Gen. Counsel & Corp. Sec.) Sale 39,428 86.12 3,395,539
2015-05-12 Stephen Falk T (EVP, Gen. Counsel & Corp. Sec.) Option Ex 39,428 40.70 1,604,916
2015-05-11 Barrett George S (Chairman and CEO) Sale 300,000 86.44 25,932,000
2015-05-11 Barrett George S (Chairman and CEO) Option Ex 300,000 27.29 8,187,000
2015-05-08 Morrison Patricia (Chief Information Officer) Sale 36,042 86.22 3,107,541
2015-05-08 Morrison Patricia (Chief Information Officer) Option Ex 36,042 41.60 1,499,347
2015-03-04 Arnold Colleen F. Sale 9,801 87.65 859,057
2015-03-04 Arnold Colleen F. Option Ex 9,801 28.80 282,268
2015-03-03 Darden Calvin Sale 9,801 87.85 861,017
2015-03-03 Darden Calvin Option Ex 9,801 28.80 282,268
2015-03-03 Notebaert Richard C Sale 9,801 88.20 864,448
2015-03-03 Notebaert Richard C Option Ex 9,801 28.80 282,268
2015-02-20 Watkins Carole S (Chief HR Officer) Sale 33,847 87.00 2,944,689
2015-02-20 Watkins Carole S (Chief HR Officer) Option Ex 33,847 27.29 923,684
2015-02-10 Barrett George S (Chairman and CEO) Sale 300,000 84.87 25,461,000
2015-02-10 Barrett George S (Chairman and CEO) Option Ex 300,000 27.29 8,187,000
2015-02-10 Watkins Carole S (Chief HR Officer) Sale 50,770 85.00 4,315,450
2015-02-10 Watkins Carole S (Chief HR Officer) Option Ex 50,770 27.29 1,385,513
2014-11-07 Blake Mark R (EVP - Strategy & Corp. Dev.) Sale 24,668 79.50 1,961,106
2014-11-07 Blake Mark R (EVP - Strategy & Corp. Dev.) Option Ex 22,488 44.30 996,218
2014-09-05 Watkins Carole S (Chief HR Officer) Sale 40,794 75.00 3,059,550
2014-09-05 Watkins Carole S (Chief HR Officer) Option Ex 40,794 41.10 1,676,633
2014-09-04 Kaufmann Michael C (CEO, Pharmaceutical Segment) Sale 50,216 74.95 3,763,689
2014-09-04 Kaufmann Michael C (CEO, Pharmaceutical Segment) Option Ex 50,216 41.10 2,063,877
2014-08-27 Henderson Jeffrey William (Chief Financial Officer) Sale 26,567 72.63 1,929,561
2014-08-27 Henderson Jeffrey William (Chief Financial Officer) Option Ex 26,567 51.49 1,367,934
2014-08-25 King David P Sale 30 73.55 2,206
2014-08-18 Blake Mark R (EVP - Strategy & Corp. Dev.) Sale 4,782 72.15 345,021
2014-08-18 Kaufmann Michael C (CEO, Pharmaceutical Segment) Sale 6,833 72.06 492,385
2014-08-18 Henderson Jeffrey William (Chief Financial Officer) Sale 78,637 72.06 5,666,582
2014-08-18 Henderson Jeffrey William (Chief Financial Officer) Option Ex 64,058 40.70 2,607,480
2014-08-11 Downey Bruce Option Ex 10,652 25.32 269,708
2014-08-08 Morford Craig S (Chief Legal/Compliance Officer) Sale 43,359 70.03 3,036,430
2014-08-08 Morford Craig S (Chief Legal/Compliance Officer) Option Ex 38,385 40.70 1,562,461
2014-08-08 Henderson Jeffrey William (Chief Financial Officer) Sale 118,093 69.72 8,233,443
2014-08-08 Henderson Jeffrey William (Chief Financial Officer) Option Ex 93,925 40.70 3,823,217
2014-07-24 Blake Mark R (EVP - Strategy & Corp. Dev.) Sale 23,114 73.41 1,696,798
2014-07-24 Blake Mark R (EVP - Strategy & Corp. Dev.) Option Ex 23,114 40.70 940,855
2014-07-24 Laws Stuart G (SVP & Chief Accounting Officer) Sale 21,266 72.50 1,541,785
2014-07-24 Laws Stuart G (SVP & Chief Accounting Officer) Option Ex 21,266 30.94 657,970
2014-07-14 Henderson Jeffrey William (Chief Financial Officer) Sale 23,632 70.65 1,669,600
2014-05-19 Blake Mark R (EVP - Strategy & Corp. Dev.) Sale 4,703 66.50 312,749
2014-05-13 Blake Mark R (EVP - Strategy & Corp. Dev.) Sale 2,822 66.50 187,663
2014-05-12 Barrett George S (Chairman and CEO) Sale 8,416 65.04 547,376
2014-05-12 Barrett George S (Chairman and CEO) Option Ex 8,416 44.16 371,650
2014-05-07 Henderson Jeffrey William (Chief Financial Officer) Sale 27,031 63.83 1,725,388
2014-02-11 Blake Mark R (EVP - Strategy & Corp. Dev.) Sale 2,330 68.53 159,674
2014-02-11 Kaufmann Michael C (CEO, Pharmaceutical Segment) Sale 315,495 67.57 21,317,997
2014-02-11 Kaufmann Michael C (CEO, Pharmaceutical Segment) Option Ex 315,495 29.11 9,185,636
2014-02-10 Kaufmann Michael C (CEO, Pharmaceutical Segment) Sale 73,500 67.00 4,924,500
2014-02-10 Kaufmann Michael C (CEO, Pharmaceutical Segment) Option Ex 73,500 27.29 2,005,815
2014-02-10 Barrett George S (Chairman and CEO) Sale 200,000 66.94 13,388,999
2014-02-10 Barrett George S (Chairman and CEO) Option Ex 200,000 44.16 8,832,000
2014-02-07 Watkins Carole S (Chief HR Officer) Sale 28,260 67.01 1,893,702
2014-02-05 Darden Calvin (Director) Sale 5,282 65.43 345,601
2014-02-05 Darden Calvin (Director) Option Ex 5,282 44.27 233,834
2014-02-05 Kenny Gregory B (Director) Sale 18,175 65.39 1,188,463
2014-02-05 Kenny Gregory B (Director) Option Ex 18,175 40.66 739,050
2014-02-04 Stephen Falk T (EVP, Gen. Counsel & Corp. Sec.) Sale 17,926 65.56 1,175,228
2014-02-04 Stephen Falk T (EVP, Gen. Counsel & Corp. Sec.) Option Ex 7,926 41.10 325,758
2014-02-04 Arnold Colleen F. (Director) Sale 8,270 65.46 541,354
2014-02-04 Arnold Colleen F. (Director) Option Ex 8,270 47.45 392,411
2014-02-04 Watkins Carole S (Chief HR Officer) Sale 46,666 65.71 3,066,422
2014-02-04 Watkins Carole S (Chief HR Officer) Option Ex 46,666 27.61 1,288,681
2014-02-04 Finn John F (Director) Sale 10,727 65.68 704,549
2014-02-04 Finn John F (Director) Option Ex 10,727 41.22 442,134
2014-02-04 Notebaert Richard C (Director) Sale 10,727 65.68 704,549
2014-02-04 Notebaert Richard C (Director) Option Ex 10,727 41.22 442,134
2014-02-03 Morford Craig S (Chief Legal/Compliance Officer) Sale 27,295 66.95 1,827,400
2014-02-03 Morford Craig S (Chief Legal/Compliance Officer) Option Ex 14,128 41.10 580,660
2013-11-11 Barrett George S (Chairman and CEO) Sale 200,000 62.71 12,542,000
2013-11-11 Barrett George S (Chairman and CEO) Option Ex 200,000 42.63 8,526,000
2013-09-30 Laws Stuart G (SVP & Chief Accounting Officer) Sale 24,879 52.01 1,293,956
2013-09-30 Laws Stuart G (SVP & Chief Accounting Officer) Option Ex 23,890 30.43 726,972
2013-09-11 Blake Mark R (EVP - Strategy & Corp. Dev.) Sale 14,584 51.53 751,513
2013-09-11 Blake Mark R (EVP - Strategy & Corp. Dev.) Option Ex 18,214 30.94 563,541
2013-08-19 Blake Mark R (EVP - Strategy & Corp. Dev.) Sale 4,925 51.27 252,504
2013-08-16 Stephen Falk T (EVP, Gen. Counsel & Corp. Sec.) Sale 10,000 51.50 515,000
2013-08-15 Morford Craig S (Chief Legal/Compliance Officer) Sale 20,000 51.33 1,026,600
2013-08-13 Barrett George S (Chairman and CEO) Sale 75,000 52.09 3,906,750
2013-08-13 Henderson Jeffrey William (Chief Financial Officer) Sale 54,590 51.99 2,838,134
2013-08-13 Henderson Jeffrey William (Chief Financial Officer) Option Ex 56,007 49.25 2,758,344
2013-08-08 Darden Calvin (Director) Sale 3,254 51.48 167,515
2013-08-08 Darden Calvin (Director) Option Ex 3,254 46.49 151,278
2013-08-05 Blake Mark R (EVP - Strategy & Corp. Dev.) Sale 29,166 51.53 1,502,923
2013-08-05 Blake Mark R (EVP - Strategy & Corp. Dev.) Option Ex 36,427 30.94 1,127,051
2013-07-26 Henderson Jeffrey William (Chief Financial Officer) Sale 76,781 50.99 3,915,063
2013-07-26 Henderson Jeffrey William (Chief Financial Officer) Option Ex 100,000 27.29 2,729,000
2013-07-18 Henderson Jeffrey William (Chief Financial Officer) Sale 57,623 49.99 2,880,573
2013-07-18 Henderson Jeffrey William (Chief Financial Officer) Option Ex 58,379 48.58 2,836,051
2013-07-15 Henderson Jeffrey William (Chief Financial Officer) Sale 14,660 49.99 732,853
2013-07-15 Henderson Jeffrey William (Chief Financial Officer) Option Ex 14,853 48.58 721,558
2013-07-11 Henderson Jeffrey William (Chief Financial Officer) Sale 83,211 48.99 4,076,506
2013-07-11 Henderson Jeffrey William (Chief Financial Officer) Option Ex 106,843 27.29 2,915,745
2013-06-19 Finn John F (Director) Sale 11,070 48.59 537,891
2013-06-19 Finn John F (Director) Option Ex 8,255 44.30 365,721
2013-05-28 Spaulding Jean G (Director) Sale 3,225 47.49 153,155
2013-05-28 Spaulding Jean G (Director) Option Ex 3,254 46.49 151,278
2013-05-24 Spaulding Jean G (Director) Sale 5,125 47.27 242,258
2013-05-24 Spaulding Jean G (Director) Option Ex 5,282 44.27 233,834
2013-05-22 Kaufmann Michael C (CEO, Pharmaceutical Segment) Sale 36 47.52 1,710
2013-05-22 Notebaert Richard C (Director) Sale 3,197 48.10 153,775
2013-05-22 Notebaert Richard C (Director) Option Ex 3,254 46.49 151,278
2013-05-20 Morford Craig S (Chief Legal/Compliance Officer) Sale 45,994 48.00 2,207,712
2013-05-20 Morford Craig S (Chief Legal/Compliance Officer) Option Ex 60,441 27.29 1,649,434
2013-05-20 Watkins Carole S (Chief HR Officer) Sale 4,612 48.00 221,376
2013-05-20 Watkins Carole S (Chief HR Officer) Option Ex 6,494 22.90 148,712
2013-05-20 Spaulding Jean G (Director) Sale 1,666 47.90 79,801
2013-05-14 Cox Carrie Smith (Director) Buy 435 46.25 20,118
2013-05-08 Morford Craig S (Chief Legal/Compliance Officer) Sale 24,070 46.19 1,111,793
2013-05-08 Morford Craig S (Chief Legal/Compliance Officer) Option Ex 30,221 27.29 824,731
2013-05-07 Blake Mark R (EVP - Strategy & Corp. Dev.) Sale 30,825 46.00 1,417,950
2013-05-07 Blake Mark R (EVP - Strategy & Corp. Dev.) Option Ex 38,350 27.91 1,070,348
2013-05-07 Morford Craig S (Chief Legal/Compliance Officer) Sale 24,070 46.06 1,108,664
2013-05-07 Morford Craig S (Chief Legal/Compliance Officer) Option Ex 30,221 27.29 824,731
2013-05-06 Stephen Falk T (EVP, Gen. Counsel & Corp. Sec.) Sale 14,253 46.14 657,633
2013-05-06 Henderson Jeffrey William (Chief Financial Officer) Sale 207,918 46.18 9,601,653
2013-05-06 Henderson Jeffrey William (Chief Financial Officer) Option Ex 205,531 34.20 7,028,132
2013-05-06 Spaulding Jean G (Director) Sale 10,447 46.19 482,546
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of CAH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cardinal Health Inc (symbol CAH, CIK number 721371) see the Securities and Exchange Commission (SEC) website.